DIALKOXYALKADIENYNE COMPOUND AND A PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING A DIENYNAL COMPOUND

    公开(公告)号:US20210061744A1

    公开(公告)日:2021-03-04

    申请号:US17010241

    申请日:2020-09-02

    IPC分类号: C07C41/26 C07C45/51

    摘要: A process for preparing a dienynal compound of the following general formula (2): CH2═CHC≡CCH═CH(CH2)nCHO (2), wherein n represents an integer of 0 to 11, the process comprising a step of hydrolyzing a dialkoxyalkadienyne compound of the following general formula (1): CH2═CHC≡CCH═CH(CH2)nCH(OR1)(OR2) (1) wherein R1 and R2 represent, independently of each other, a monovalent hydrocarbon group having 1 to 15 carbon atoms, preferably 1 to 8, mere preferably 1 to 4, or R1 and R2 may be bonded to each other to form a divalent hydrocarbon group, R1-R2, having from 2 to 10 carbon atoms, and n represents an integer of 0 to 11, to obtain the dienynal compound (2).

    DIARYLALKANES AS POTENT INHIBITORS OF BINUCLEAR ENZYMES

    公开(公告)号:US20200170907A1

    公开(公告)日:2020-06-04

    申请号:US16780018

    申请日:2020-02-03

    申请人: Unigen, Inc.

    发明人: Qi Jia Ji-Fu Zhao

    摘要: The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds—diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier.